potent and selective TAS2R8 GPCR antagonist

approved non-systemic bitter taste blocker

from 200k cmpd cell-based screen and opt.

J. Med. Chem., Apr. 24, 2020

Firmenich SA, San Diego, CA


S6821 is one of two potent and selective TAS2R8 GPCR antagonists disclosed by Firmenich, a fragrance and flavor company. These compounds block bitter taste receptors and don’t have significant systemic…

get free samples and a Premium trial

Premium members get access to our library of hundreds of in-depth reviews on key molecules, ten new reviews each month, novel drug approval coverage, drug discovery company updates, and more: